Partnerships, Licensing, Investments and M & A Deals and Trends in Pharmaceuticals – Q2 2011

NEW YORK, Aug. 25, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:

Partnerships, Licensing, Investments and M&A Deals and Trends
in Pharmaceuticals – Q2 2011

http://www.reportlinker.com/p0293171/Partnerships-Licensing-Investments-and-MA-Deals-and-Trends-in-Pharmaceuticals—Q2-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Healthcare

Partnerships, Licensing, Investments and M&A Deals and
Trends in Pharmaceuticals – Q2 2011

Summary

GlobalData’s “Partnerships, Licensing, Investments and M&A
Deals and Trends in Pharmaceuticals – Q2 2011” report is an
essential source of data and trend analysis on partnerships,
licensing, mergers and acquisitions (M&A) and financing in the
pharmaceutical and healthcare market. The report provides detailed
information on partnerships, licensing agreements, M&As,
equity/debt offerings, private equity and venture financing
transactions recorded in the pharmaceutical and healthcare industry
in Q2 2011. The report presents detailed comparative data on the
number of deals and their value in the last five quarters,
categorized into deal types, segments, and geographies. The report
also provides information on the top venture capital and advisory
firms in the pharmaceutical and healthcare industry.

GlobalData derived the data presented in this report from
proprietary in-house Pharma eTrack deals database and primary and
secondary research.

Scope

– Analysis of the market trends for the pharmaceutical industry
in the globa

‘/>”/>

SOURCE